News on Compugen from BioPortfolio.com http://www.BioPortfolio.com Consolidated Compugen news from BioPortfolio.com Wed, 10 Feb 2010 15:41:35 GMT en Three Questions Facing the Future of Compugenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039513&HITNO=0&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039513&THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039513&HITNO=0&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039513&THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Market Media: Compugen share jumps as loss again narrows: RandD expenses of $1.6m last year were the drug development company's largest expense.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039447&HITNO=1&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039447&THISHREF=http://c.moreover.com/click/here.pl%3fz2538119163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039447&HITNO=1&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039447&THISHREF=http://c.moreover.com/click/here.pl%3fz2538119163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Compugen Cuts Q4 Loss on Decreased Spendinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041223&HITNO=2&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041223&THISHREF=http://c.moreover.com/click/here.pl%3fz2539040083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041223&HITNO=2&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041223&THISHREF=http://c.moreover.com/click/here.pl%3fz2539040083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Compugen share jumps as loss again narrows: RandD expenses of $1.6m last year were the drug development company's largest expenshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037848&HITNO=3&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037848&THISHREF=http://c.moreover.com/click/here.pl%3fz2537331191%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037848&HITNO=3&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037848&THISHREF=http://c.moreover.com/click/here.pl%3fz2537331191%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036887&HITNO=4&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036887&HITNO=4&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036382&HITNO=5&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536592031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036382&HITNO=5&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536592031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035239&HITNO=6&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035239&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035239&HITNO=6&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035239&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034944&HITNO=7&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034944&THISHREF=http://c.moreover.com/click/here.pl%3fz2536059661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034944&HITNO=7&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034944&THISHREF=http://c.moreover.com/click/here.pl%3fz2536059661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Fourth-quarter and full-year 2009 results announced by Compugenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034703&HITNO=8&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535935499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034703&HITNO=8&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535935499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Pfizer 'invests to win'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024371&HITNO=9&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024371&THISHREF=http://c.moreover.com/click/here.pl%3fz2528850581%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024371&HITNO=9&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024371&THISHREF=http://c.moreover.com/click/here.pl%3fz2528850581%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: News and FDA Updates for Compugen (NASDAQ:CGEN), Depomed (NASDAQ:DEPO), Dyax (NASDAQ:DYAX)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011401&HITNO=10&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011401&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011401&HITNO=10&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011401&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: News and FDA Updates for Compugen (NASDAQ:CGEN), Emisphere (OTC:EMIS), EpiCept (Nasdaq:EPCT)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011399&HITNO=11&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011399&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011399&HITNO=11&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011399&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Compugen discovers new protein for autoimmune diseases treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010936&HITNO=12&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010936&THISHREF=http://c.moreover.com/click/here.pl%3fz2522671008%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010936&HITNO=12&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010936&THISHREF=http://c.moreover.com/click/here.pl%3fz2522671008%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Compugen Ltd. to Review Fourth Quarter and Year-End 2009 Financial Results on Tuesday, February 9, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005263&HITNO=13&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005263&THISHREF=http://c.moreover.com/click/here.pl%3fz2520301097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005263&HITNO=13&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005263&THISHREF=http://c.moreover.com/click/here.pl%3fz2520301097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Compugen discovers CGEN-15001 protein for treatment of autoimmune disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002668&HITNO=14&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002668&THISHREF=http://c.moreover.com/click/here.pl%3fz2519105607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002668&HITNO=14&MSIZE=39&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Compugen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002668&THISHREF=http://c.moreover.com/click/here.pl%3fz2519105607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: